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Abstract.  DVRo6 (BMP-6 or Vgr-1) is a member of 
the TGF-B superfamily of polypeptide signaling mole- 
cules. In situ hybridization studies have previously 
shown that DVR-6 RNA is expressed in a variety of 
cell types in the mouse embryo, but no information 
has been available on protein localization and biosyn- 
thesis. We have produced a polyclonat antibody to the 
proregion of DVR-6 and used it to localize the protein 
in whole mount and sectioned embryonic, newborn, 
and adult mouse tissues. DVR-6 protein is expressed 
in the mouse nervous system beginning at 9.5 days 
postcoitum (d.p.c.) and continues through adulthood. 
A variety of epithelial tissues also produce DVR-6 
protein, including the suprabasal layer of the skin, 
bronchiolar epithelium, and the cornea. Additionally, a 
stably transfected cell line, BMGE+H/D6c4,  is used 
to study the biosynthesis of DVR-6 protein and evi- 
dence is presented for translational regulation of 
DVR-6 expression. 
T 
hE transforming growth factor beta (TGF-B)~ super- 
family is a large group of signaling polypeptides with 
multiple biological  activities  in  vivo and  in  vitro 
(Soma and Grotendorst,  1989;  Sato et al.,  1990;  Kehrl, 
1991; Massague et al.,  1991). Members of this family are 
secreted, disulfide-bonded dimers of •25,000-30,000  Mr, 
proteolytically cleaved from larger precursors.  The deca- 
pentaplegic-Vg-related  (DVR) subgroup of the TGF-B super- 
family  contains  members closely  related  to  Drosophila 
decapentaplegic (DPP), Xenopus  Vg-1, and mammalian  bone 
morphogenetic  proteins  (BMPs)  (Lyons  et  al.,  1991). 
Genetic analysis has shown that DPP is required at several 
different stages of embryogenesis, such as dorso-ventral pat- 
terning of the blastoderm, proximal-distal patterning of the 
imaginal discs, and midgut morphogenesis (Irish and Gel- 
bart,  1987;  Posakony  et  al.,  1990;  Panganiban  et  al., 
1990a). Additionally, studies have been reported on the bio- 
chemical characterization of DPP protein, its localization in 
tissues using specific antibodies, and the identification of 
genes that regulate and interact with DPP during develop- 
ment (Panganiban et al.,  1990b; Immergluck et al.,  1990; 
Ferguson and Anderson, 1992).  In contrast, much tess is 
known about the role of Xenopus Vg-I (DVR-I) and the other 
DVR genes in vertebrate embryonic development. In situ hy- 
bridization studies and RNase protection experiments have 
demonstrated that several members of this subgroup are ex- 
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pressed in a  variety of tissues throughout development in 
mouse and Xenopus, in particular in tissues undergoing in- 
ductive interactions (Weeks and Melton 1987; Lyons et al., 
1989a,b, 1990;  Jones et al.,  1991). However,  functional 
studies with purified protein have been limited to either ec- 
topic bone and cartilage induction in mammals, or meso- 
derm induction in Xenopus (Wang et al., 1990; Jones et al., 
1992; Dale et al.,  1992). 
As stated above,  specific antibodies against Drosophila 
DPP have been invaluable for studying the biosynthesis of 
DPP and demonstrating the  in  vivo localization  of  the  pro- 
tcin.  Clearly,  this  approach is  an  important step  towards un- 
derstanding  the  biological  role  of  vertebrate  DVR proteins. 
We report  here the production of an affinity-purified  anti- 
body, c~DVR-6, against  the  proregion of  mouse DVR-6 that 
specifically  recognizes this protein and not the closely 
related  proteins,  DVR-5 or  -7.  We have  used  aDVR-6 to  fol- 
low biosynthesis  of  DVR-6 in  cultured  cells  and to localize 
the  precursor  protein  in the  cytoplasm of  cell  lines  and in  a 
variety  of  embryonic, neonatal,  and adult  tissues.  These in- 
clude  the  suprabasal  layers  of  the  epidermis,  the  bronchiolar 
epithelium  of  newborn lung,  adult  cornea, and cells  of  the 
nervous system. In the case of neuronal tissue,  protein  is 
localized  not only in the cell  bodies but also  at high levels 
in the axons, suggesting  that  DVR-6 is an axonally trans- 
portecl  protein.  However, we were not  able  to  detect  the  pro- 
tein  in  several  other  tissues  and  two  cell  lines  (PYS and  49F) 
that  express  DVR-6 mRNA  by in situ  hybridization,  North- 
crn analysis,  and RNase protection  analysis.  This suggests 
that  there  is  posttranscriptional  regulation  or  modification  of 
DVR-6. 
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Antigen Production 
A glutathione-S-transferase  (GST)/DVR-6  fusion protein was made using 
the pGEX  system  described by  Smith and Johnson (1988).  A  256-bp 
XhoIFRsaI fragment (nucleotides  180 to 436) of the mouse DVR-6 cDNA 
designated  Vgr-1 (Lyons  et al.,  1989a)  encoding part of the proregion 
was inserted into the Sinai site at the 3' end of the GST-coding region in 
the pGEX 2T vector.  This region of Vgr-1 was chosen because it encodes 
the part of the DVR-6 protein that has diverged most extensively  from the 
closely related proteins DVR-5 and DVR-7 (BMP-5 and BMP-7, Celeste et 
al.,  1990). Comparison of the predicted amino acid sequence of hDVR-6 
with that of hDVR-5  and hDVR-7  in the  region used  for making the 
GST/DVR-6 fusion protein reveals only 36.8 and 33.3%  identity, respec- 
tively (Celeste  et al.,  1990). 
Preparation of antigen is described elsewhere (Wall et al.,  1992). 
Antibody Preparation and Specificity 
Female New Zealand rabbits were injected initially subcutaneously  and in- 
tramuscularly in a total of four sites with a total of 750 #g of GST/DVR-6 
fusion protein emulsified  in Freund's complete adjuvant.  Approximately 
24% of this total represents DVR-6 protein. Subsequently,  750-~g boosts 
were in Freund's incomplete adjuvant. Antibody preparation and specificity 
were determined by previously  described methods (Wall et al.,  1992). 
In Vitro Transcription of DVR-5, -6, and -7 RNA 
The full-length human DVR-5, -6, and -7 cDNAs were used for in vitro tran- 
scription of RNA. Linearized DNA template (inserted behind an SP6 pro- 
moter) was incubated with the following: 5 mM m7G(5')ppp(5')G (Pharma- 
cia LKB Biotechnulogy Inc., Piscataway, NJ); 5 mM rATP, rCTP, and rUTP 
and 0.5 mM rGTP; RNase inhibitor; transcription  buffer; and SP6 polymer- 
ase (all from Promega Corp., Madison, WI). Transcription product was 
then incubated with RNase-free  DNase I (Promega Corp.). 
In Vitro Translation 
1 #1 of in vitro transcription product was incubated with RNase inhibitor 
(Promega Corp.), translation buffer, rabbit reticulocyte  lysate,  and 1 mM 
amino acid mix minus methionine (rabbit reticulocyte  lysate kit, Promega 
Corp.) and 2 #1 ail-trans [35S]methionine (1,000 Ci/mmol; ICN Biomedi- 
cals, Inc., Costa Mesa, CA). The volumes of translation product used for 
immunoprecipitation were  adjusted  to give  equal amounts  of TCA-pre- 
cipitable radioactivity. 
Immunoprecipitation 
Translation  product was  incubated with either normal rabbit serum or 
c~DVR-6 in 400 mM NaC1, 50 mM Tris, pH 8.0, 5 mM EDTA, and 1% NP- 
40  (NET  buffer).  Antigen-antibody  complex  was  bound  to  protein 
A-Sepharose (Sigma  Chem. Co.,  St.  Louis, MO) prewashed  with NET 
buffer, and analyzed by SDS-PAGE (under reducing conditions) and autora- 
diography. 
Transfection, Culture, and Labeling of 
Bovine Mammary Gland Epithelial (BMGE) Cells 
and PYS cells 
Cells of the BMGE+H line (Schmid et al., 1983) were cotransfected  with 
the coding region of human DVR-6 under the control of the keratin HI and 
IV* regulatory elements (Blessing et al., 1987) and the neomycin resistance 
gene marker plasmid pAG60 (Colb~re-Garapin  et al.,  1981). Transfection 
was performed by the calcium phosphate technique (Gorman et al., 1982). 
Clones were selected  in DME supplemented with 20% FBS/I% penicil- 
lin/streptomycin/l% glutamine/1  t~g/ml each  of prolactin,  insulin,  and 
hydrocortisone/800  ~,g/ml geneticin. After selection, confluent monolayers 
in 60-ram plates were preincubated in methionine-frce DME for 30 rain and 
then labeled with 200 ~g/ml [sSS]methionine (ICN Biomedicals,  Inc.) for 
2.5 h at 37~  The medium was collected and the cytoplasmic  fraction was 
obtained by adding 50 mM Tris, pH 8, 150 mM NaC1, 5 mM EDTA, and 
1% NP-40 for 3 min at room temperature.  After centrifugation to remove 
aggregated material, 200 t~l of medium or 100 #1 of the cytoplasmic fraction 
was incubated with equal amounts of IgG from either normal rabbit serum 
or aDVR-6 in 1 ml NET buffer for 1.5 h at room temperature.  Antigen-anti- 
body complex was bound to protein A-Sepharose (Sigma  Chem.  Co.), 
prewashed  with NET buffer, and analyzed by SDS-PAGE and autoradiog- 
raphy. 
PYS cells were transfected by the calcium phosphate method with a sin- 
gle plasmid containing hDVR-6 under the control of the/5-actin promoter 
and a  neomycin  resistance gene.  PYS  cells were grown in DME  sup- 
plemented with 5% FBS/1% penicillin/streptomycin and 1% glutamine. 
RNAse Protection Assay 
The 256-bp XhoIVRsaI fragment used to make the GST/DVR-6 fusion pro- 
tein was also used to make the antisense RNase protection probe. Probe was 
labeled with [32P]UTP (800 Ci/mmol;  New  England Nuclear,  Boston, 
MA).  Total RNA from PYS cells was combined with 5  x  105 cpm of 
probe in 50% formamide, 40 mM Pipes, pH 7.6, 400 mM NaCI, and 1 mM 
EDTA (hybridization buffer). This mixture was incubated at 85~  for 5 min, 
and then at 50~  overnight.  Subsequently, unhybridized RNA was digested 
in 300 #1 of 10 mM Tris, pH 7.4, 5 mM EDTA, 150 mM NaCi, 83.3 #g/ml 
RNase A, and 16.7 U/ml RNase Tt for 30 min at room temperature.  Diges- 
tion was stopped by adding 0.5 % SDS and Proteinase K to a final concentra- 
tion of 120 #g/ml and incubating at 37~  Protected RNA was purified by 
phenol/chloroform  extraction and ethanol precipitation, analyzed on an 8 % 
sequencing  gel, and visualized  by autoradiography. 
Western Blot Analysis 
Dissected tissues (heads, livers,  spinal cords, and limb buds) were placed 
directly  into 10 vol of sample buffer containing 5% fl-mercaptcethanol, 
2.3% SDS, 62 mM Tris.HCl, pH 6.8, and 10% glycerol,  and then boiled 
for 5 min and either used immediately or stored at -20~  SDS-PAGE was 
performed using a  12%  separating  gel,  and proteins were then electro- 
blotted to a nylon filter (Amersham Corp., Arlington Heights,  IL). The 
filter was blocked with 5% FBS,  1% BSA, 0.5% Tween 20, 0.1 M MgCI2, 
0.01 M Tris.HC1, pH 7.4. DVR-6 protein was detected by incubation with 
affinity-purified primary antibody diluted 1:1,000 in TBST followed by incu- 
bation with a 1:5,000 dilution of goat anti-rabbit IgG conjugated to peroxi- 
dase (Boehringer Mannheim Corp., Indianapolis,  IN) and subsequently  in- 
cubated with a  1:5,000  dilution of goat anti-peroxidase conjugated  to 
peroxidase (Cappell Laboratories, Malvern, PA, 0100-1221). All antibodies 
were preincuhated with mouse liver acetone powder before use (I-Iarlow and 
Lane, 1988). The luminol solution from Amersham's ECL kit (RPN.2109) 
was used as a substrate for peroxidase,  and the resulting chemiluminescent 
reaction was detected on XAR-5 film (Eastman Kodak Co., Rochester, NY). 
Fixation and Immunohistochemical Staining of 
Embryos and Cells 
Fixation of embryos is described elsewhere (Wall et al., 1992). Cells were 
cultured on glass coverslips, fixed in methanol/DMSO (4:1) 2 rain at room 
temperature, treated to inhibit endogenous  peroxidase activity,  rinsed in 
PBS, and used immediately for immunohistochemistry.  Immunohistochem- 
ical methods used on whole and sectioned embryos are described elsewhere 
(Wall et al.,  1992). 
Results 
Specificity and Species Crossreactivity of clDVR-6 
The  amino  acid  sequence  of  the  DVR-6  portion  of the 
GST/DVR-6  fusion  protein  used  for  immunization  (see 
Materials  and Methods) was compared to sequences in the 
EMBL database  (Brutlag et al., 1990) to determine if there 
were any other known proteins which might be recognized 
by  the antibody.  No protein sequences  showed more than 
22 % similarity. To confirm that o~DVR-6 does not cross-react 
with its  closest family members,  immunoprecipitation ex- 
periments were carried out using human  DVR-5,  -6, and -7 
(BMP-5, -6, and -7) protein synthesized in vitro. Fig. 1 shows 
that o~DVR-6 only recognizes DVR-6 protein. 
Further  evidence  demonstrating  the  specificity  of  the 
DVR-6 antibody  is shown in Figs. 2 and 3. BMGE+H cells 
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mouse  DVR-6  in  PYS  cells. 
(Lane  /),  256-bp  XholI/RsaI 
probe; (lane 2), 512-bp protected 
fragment;  and  (lane  3),  probe 
with water as a negative control. 
Figure 1. In vitro translation of DVR-5, -6, and -7 RNA and immu- 
noprecipitation of translation products with cxDVR-6. (Lanes 1-3) 
Human DVR-5, -6, and -7 protein, respectively. (Lanes 4-6) Immu- 
noprecipitation,  using  otDVR-6, of human  DVR-5, -6,  and  -7, 
respectively. The positions of  protein markers are shown in kilodal- 
tons on the fight. 
Figure 2. Immunohistochemistry of BMGE cells stably transfected 
with hDVR-6 using (a) aDVR-6 and (b) normal rabbit serum, n, 
nucleus. Bars, 20/~m. 
Figure 3. Immtmoprecipitation of newly synthesized protein made 
by BMGE  (lanes 1-4)  and BMGE/D6c4  (lanes 5-8) cells  with 
ctDVR-6. (Lanes I and 5) Medium + normal rabbit serum; (lanes 
2 and 6) medium +  otDVR-6; (lanes 3 and 7) cytoplasmic fraction 
+  normal rabbit serum; and (lanes 4 and 8) cytoplasmic fraction 
+ txDVR-6. The positions of protein markers are shown in kilodal- 
tons on the fight. 
were stably transfected with the entire coding region of hu- 
man DVR-6 cDNA in a cytokeratin-based expression vector. 
Immunohistochemistry  (Fig.  2)  and  immunoprecipitation 
(Fig. 3) experiments show that the antibody recognizes pro- 
tein in the transfected cell line BMGE+H/D6c4 but not in 
untransfected control cells. 
Mouse DVR-6 cDNA sequence was used to make the fu- 
sion protein antigen. However, the resulting antibody recog- 
nizes human (Figs.  1-3) and chicken (Kuratani, S., Baylor 
College of Medicine, personal communication) DVR-6 pro- 
tein. The chicken DVR-6 amino acid sequence is not known, 
but the mouse and human sequence have 81.6 % identity in 
the region used to make the antigen. Therefore, otDVR-6 is 
useful for studies in at least three species. 
Expression in Cell Lines 
Lyons et al. (1989a,b) showed, using Northern analysis, that 
DVR-6 (Vgr-1) RNA is expressed in three cell lines-murine 
PYS,  human 49E  and human HT1080.  However, of these 
three,  immunoreactivity for c~DVR-6 is  only seen  in  the 
cytoplasm of  the HT1080 cell line (data not shown). This dis- 
crepancy between mRNA and protein expression could have 
several explanations. For example, there may be alternative 
splicing of the DVR-6 transcript in PYS and 49F cells that 
removes  the  region  encoding  the  epitope  recognized  by 
c~DVR-6. However, results of RNase protection assays dem- 
onstrate that the RNA sequence encoding the epitope recog- 
nized by c~DVR-6 is present in PYS cells (Fig. 4). Another 
explanation is that translation of the mRNA is inhibited, per- 
haps through 5' or 3' untranslated  sequences.  Preliminary 
experiments which support this idea show that an hDVR-6 
construct,  without  any  5' or  3' untranslated  sequence,  is 
translated when transfected into PYS cells. Other explana- 
tions are that the translation product is complexed with an- 
other protein, obscuring the epitope recognized by c~DVR-6, 
or that DVR-6 protein is quickly degraded upon synthesis. 
Experiments to distinguish between these possibilities are 
currently under way. 
Biosynthesis  of DVR-6 Protein 
Biosynthesis of hDVR-6 protein was examined using the sta- 
bly transfected cell line,  BMGE+H/D6c4.  The predicted 
relative molecular mass of the precursor protein is 5%207 
and the in vitro-translated (therefore, unmodified) DVR-6 
protein is ~58,000 (Fig. 1). Fig. 3 shows that newly synthe- 
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d.p.c, mouse tissue with ~DVR-6. 
(Lane  /)  Head;  (lane 2)  liver; 
(lane 3) spinal cord; and (lane 4) 
limb bud. The positions of pro- 
tein markers are shown in kilo- 
daltons on the right. 
Figure 5. Immunoprecipitation  of newly synthesized  protein made 
by BMGE/D6c4 cells with and without tunicamycin treatment. 
(Lanes I and 2) Medium of untreated cells with normal rabbit se- 
rum (NRS) and CDVR-6, respectively. (Lanes 3 and 4) Medium of 
tunicamycin-treated cells  with c~DVR-6 and  NRS, respectively. 
(Lanes 5 and 6) Cytoplasmic fraction of untreated cells with NRS 
and r  respectively. (Lanes 7 and 8) Cytoplasmic fraction 
of tunicarnycin-treated  ceils with c~DVR-6 and NRS, respectively. 
The positions of protein markers are shown in kilodaltons on the 
right. 
sized DVR-6 protein in the cytoplasm of BMGE+H/D6c4 
cells  exists  as  ,~62,000/65,000-Mr  doublet.  This  doublet 
most likely represents different glycosylated forms of full- 
length DVR-6  protein  (Wang,  E.,  Genetics Institute, per- 
sonal communication and see below). The predicted relative 
molecular mass for the proregion alone of DVR-6 protein is 
42,370.  Therefore, another doublet of •40,500/43,500  Mr 
found in the medium probably represents this part of the pro- 
tein which is cleaved from the mature region around the time 
of secretion (lane 6, Fig. 3). The appearance of this doublet 
as diffuse rather than sharp bands is indicative of partially 
degraded, glycosylated protein. 
To demonstrate that DVR-6 protein is glycosylated, immu- 
noprecipitation experiments  were  repeated using cultures' 
treated with tunicarnycin (Fig. 5). The lower doublet is not 
seen in the medium but a  protein of '~41,500 Mr is now 
seen  in  the  cytoplasm.  This  protein  species  most  likely 
represents the cleaved proregion of DVR-6 which, perhaps 
due to lack of  glycosylation, is not secreted into the medium. 
Also,  the  --62,000/65,000-Mr  doublet found in the cyto- 
plasm of control cells is no longer present, but is replaced 
by a  single '~55,000-Mr  protein.  This species most likely 
represents the unglycosylated form of the DVR-6 precursor. 
Western blot analysis of 12.5 days postcoitum (d.p.c) em- 
bryonic tissue was performed to demonstrate that DVR-6 
protein is present in vivo.  Tissues that are immunoreactive 
for aDVR-6 by immunohistochemistry-namely, brain and 
spinal cord-and tissues that are not immunoreactive for the 
antibody-liver and limb bud-were used. Fig. 6 shows that 
the cleaved proregion, the "40,500/43,500-Mr  doublet, is 
present in brain (head) and spinal cord, but not in liver and 
limb buds. No uncleaved protein was detected by Western 
blot, but it is detectable by immunoprecipitation of labeled 
tissues (data not shown). 
Localization of  DVR-6 Protein In Vivo 
Previous  studies  using  in  situ hybridization had revealed 
DVR-6 RNA in a number of embryonic tissues including the 
central nervous  system, skin,  hypertrophic cartilage,  and 
primary oocytes. Intact and sectioned embryos were studied 
by immunohistochemistry to see if localization of DVR-6 
protein correlates with previously published RNA expres- 
sion patterns (Lyons et al.,  1989a,b). 
Expression of  DVR-6 in the Developing Mouse 
Nervous System 
Using whole mount immunohistochemistry with mouse em- 
bryos, DVR-6 protein is first detected at 9.5 d.p.c., in the de- 
veloping trigeminal mesencephalic tracts, cranial nerves and 
ganglia, and spinal nerves of the anterior spinal cord (Fig. 
7 a). Immunoreactivity was not seen in 9.0 d.p.c, embryos. 
By 10.5 d.p.c., as neural development proceeds, expression 
is maintained in these areas and is also seen in the spinal 
nerves emerging from more posterior regions of the spinal 
cord (Fig. 7, b and c). 
Localization of protein was studied in more detail in trans- 
verse sections of embryos at 9.5,  10.5, 12.5, and 15.5 d.p.c. 
As the nervous system develops, the number of DVR-6-posi- 
tive cells increases (Fig. 8). Immunoreactivity at 9.5 d.p.c. 
in the anterior regions of the spinal cord is in cells located 
in lateral and ventral regions of the marginal zone. DVR-6 
protein is also seen in putative neural crest cells that presum- 
ably will contribute to the formation of the cranial ganglia. 
By 10.5 d.p.c., the cranial and dorsal root ganglia and the 
presumptive motor neurons are immunoreactive and express 
DVR-6 protein in cell bodies as well as axons. This is partic- 
ularly evident in Fig. 8 e. At 12.5 d.p.c., both the cell bodies 
throughout the spinal cord and the axonal tracts which form 
the  white matter are  heavily stained,  again showing that 
DVR-6 protein is present in axons as well as cell bodies and, 
therefore,  is  probably  transported  and  secreted  axonally. 
However,  by 15.5 d.p.c., the staining of axon tracts is re- 
duced. 
In newborn mice, expression is in most regions of the 
brain but is more obvious in areas which contain larger cells 
or more concentrated neuronal populations such as the cere- 
The Journal  of Cell Biology,  Volume 120, 1993  496 Figure  7.  Immunohistochemistry of intact 9.5- and 10.5-d.p.c. mouse embryos. (a) 9.5-d.c.p. mouse embryo with normal rabbit serum. 
(b) 9.5-d.p.c. mouse embryo. Arrows indicate the developing spinal nerves, tin, trigeminal mesencephalic tract. (c) 10.5-d.p.c. mouse em- 
bryo. Cranial nerves are numbered. Arrow shows the trigeminal mesencephalic tract, or,  otic vesicle; lb, limb bud. (a  t) Boxed area in c. 
Arrows show the ventral motor roots of the spinal nerves. Asterisks show the dorsal roots of the spinal nerves. Bars: (a-c) 500/an; (a  t) 
100 #m. 
Wall et al. Biosynthesis and In Vivo Localization of DVR-6 Protein  497 Figure 8. Immunohistochemistry of sections through the developing spinal cord and hind brain. (a) 9.5-d.p.c. hindbrain, branchial arch 
region. Note immunoreactive cells in the periphery of the neural tube, including presumptive motor neurons. (b) 10.5-d.p.c. spinal cord. 
Arrow shows the ventral commissural tract. (c) 12.5-d.p.c. spinal cord. Arrows show heavy staining of axonal tracts. (d) Magnification 
of boxed area from a. Arrows show putative neural crest cells. (e) Magnification of boxed area from b. Note strong cytoplasmic staining 
of motor neuron cell bodies and axons exiting from the spinal cord (arrows). (f)  15.5 d.p.c. Arrows show decreased staining of axonal 
tracts compared to 12.5 d.p.c, drg, dorsal root ganglion; m, motor neurons; sc, spinal cord. Bars: (a and b) 100 txm; (c and f) 50 t,m; 
(d and e) 25 ~m. 
bellum,  hippocampus,  and brain nuclei (data not shown). 
Fig. 9 shows that this expression is maintained in the adult. 
DVR-6 protein immunoreactivity is seen in the cerebellum 
(Fig. 9, a  and c) and in the hippocampus (Fig. 9, b and d). 
While protein can be definitely localized to neuronal cells, 
we cannot at present exclude the possibility that it is also ex- 
pressed in some glial cells. However, in counterstained sec- 
tions of the eye it was apparent that there were glial cells 
which did not express DVR-6 protein. Additionally, in the 
adult,  but  not  in  embryos  or  newborns,  o~DVR-6  im- 
munoreactivity is seen in the choroid plexus (Fig. 9 b) and 
meninges (data not shown). 
Fig. 9 also shows the developing eye (Fig. 9 e) and cochlea 
(Fig. 9f) ofa 15.5-d.p.c. embryo. As seen in the spinal cord, 
DVR-6 immunoreactive cells are limited to the most mature 
region of  the retina and the axon tract of  the optic nerve, indi- 
cating that this protein is expressed in postmitotic neurons. 
In the cochlea, expression of DVR-6 protein is seen in the 
eighth cranial nerve and the region containing hair cells in 
the cochlear duct wall. 
Expression in Epithelia 
DVR-6  protein  is  first detected in  the  epidermis  at  15.5 
d.p.c., specifically in the nasal epithelium, when it is begin- 
ning to thicken and keratinize (Fig. 10, a-d). By 16,5 d.p.c., 
expression is seen in the suprabasal cells of the skin, but is 
absent from the basal layer and hair follicles. This correlates 
with  the  expression  of  DVR-6  mRNA  (Lyons  et  al., 
1989a,b).  In newborn mice, cxDVR-6 immunoreactivity is 
The Journal of Cell Biology,  Volume 120, 1993  498 Figure  9.  Immunohistocbemistry of brain and sensory organs. (a) Adult cerebellum. Arrow shows Purkinje cell layer. (b) Adult hip- 
pocampus. Arrow shows pyramidal cell layer. Asterisk denotes choroid plexus which is intensely immunoreactive. (c) High power view 
of the Purkinje cell layer. Arrows show Purkinje cells. (d) High power view of the pyramidal cell layer. Arrow shows an axon extending 
from a pyramidal cell. (e) 15.5-d.p.c. eye and optic nerve. Arrows show immunoreactivity in the retinal ganglion cells and axons in the 
optic nerve (l/). The staining in the lens is nonspecific. (f) Horizontal section of a 15.5-d.p.c. cochlea. Arrows show immunoreactivity 
in hair cells of the sensory epithelium. Cranial nerves and hippocampal regions are numbered, nmc, nucleus medialis cerebellum; dg, 
dentate gyrus; t, thalamus; cp, choroid plexus; too, molecular layer; g, granule cell layer; or, striatum oriens; py, pyramidal layer; rad, 
striatum radiens; l, lens; vb, vitrious body; r, retina; cd, cochlear duct. Bars: (a and b) 200 gm; (c and at) 25 #m; (e) 100 #m; (f) 50 #m. 
still seen in the suprabasal layer of the epidermis. Addition- 
ally, all of the corneal epithelial cells of the adult are DVR-6 
immunoreactive, but not the limbus (Fig. 10, g-i). Since the 
epithelial  cells  of the  cornea  migrate  centripetally  from 
the limbus, this expression pattern is analogous to that of the 
skin in which the basal cell layer (mitotic region) does not 
express DVR-6 protein, while the suprabasal layer (postmi- 
totic) does express DVR-6 protein. Fig.  10, e and f, shows 
that DVR-6 protein also is expressed in the bronchiolar epi- 
thelium of newborn lung but not in alveolar epithelium. 
Other Tissues 
Hypertrophic cartilage, uterine stroma, and oocytes, tissues 
that previously had been shown by in situ hybridization to 
express DVR-6 mRNA,  were also examined by immuno- 
histochemistry. Hypertrophic cartilage in late-stage embryos 
was not immunoreactive for r  Ovaries and uteri from 
each day of the estrous cycle were stained but showed no im- 
munoreactivity in the oocytes or uterine stroma. Addition- 
ally,  both  fertilized and  unfertilized ova taken  at  various 
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skin. (d) Newborn skin with normal rabbit serum. Arrows indicate basal cells which show little or no expression of DVR-6 protein. (e) 
Newborn lung. Arrows indicate areas of positive staining. O  High power view of newborn lung (boxed area in e). Immunoreactivity is 
seen in the bronchiolar epithelium (asterisk) but not the alveolar epithelium (arrow). (g) Adult cornea. (h) Adult cornea with NRS. (i) 
Limbus region of adult eye. Open arrow shows trailing edge of the DVR-6 positive cornea. Arrow shows where corneal epithelium ends. 
Bars: (a-d and f) 25 #m; (e) 200/~m; (g and h) 20 #m; (i) 50 ttm. 
times after ovulation were also immunostained, but again 
showed no immunoreactivity with aDVR-6. 
Discussion 
The  availability  of  a  specific  antibody  for  DVR-6  has 
provided a means for in-depth studies of its synthesis, post- 
translational modification, secretion, and localization in at 
least three species (mouse and human, this paper; chicken, 
Kuratani, S.,  unpublished observations).  Although in situ 
hybridization studies have previously shown expression pat- 
terns for DVR-6 during development, these studies only es- 
tablish where mRNA is located, not the protein. Since pro- 
teins are the agents of function, and since the presence of a 
transcript does not necessarily indicate translation, a protein 
expression pattern, as well as characterization of  the protein, 
is important for examining the potential role of DVR-6 in the 
developing embryo. 
Immunoprecipitations  done  with  aDVR-6  reveal  two 
newly synthesized protein doublets of ~,62,000/65,000 and 
",,40,500/43,500  Mr in cells transfected with hDVR-6 and in 
tissues of developing mouse embryos (Fig. 3 and data not 
shown). Since c~DVR-6 only recognizes the proregion of the 
protein, it is likely that the higher doublet is the full-length 
DVR-6 protein and the lower is the cleaved proregion. This 
is consistent with the model that DVR-6 protein, as a mem- 
ber of the TGF-fl superfamily, is  synthesized as a  prepro 
secreted protein (Brunner et al., 1988; Gentry et al., 1988; 
Sha et al.,  1989). 
DVR-6 protein, which has five potential N-glycosylation 
sites (two in the proregion and three in the mature region), 
exists in two glycosylated forms and at least its proregion is 
secreted  from cells.  The significance of two glycosylated 
forms of this protein is presently unknown, but it appears 
that glycosylation may affect secretion of DVR-6  protein 
since tunicamycin treatment of BMGE+H/D6c4 cells shows 
that secretion of the cleaved proregion of DVR-6 is inhibited 
when it is unglycosylated (Fig. 6). Absence of glycosylation 
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region of DVR-6 protein. An antibody to the mature region 
is currently being produced so that this can be determined. 
In  situ  hybridization  studies  have  shown  that  DVR-6 
mRNA  is  expressed  in  epithelia  and  neural  tissues,  hy- 
pertrophic  cartilage,  and primary  oocytes  (Lyons et  al., 
1989a,b).  Although ctDVR-6 recognizes protein in neural 
and epithelial tissues, it does not detect DVR-6 protein in 
hypertrophic cartilage or oocytes. This discrepancy between 
mRNA and protein expression is also found in cell lines that 
contain DVR-6 transcripts. While HT1080 cells express both 
DVR-6 mRNA and protein, PYS and 49F cells, which con- 
tain DVR-6 transcripts, do not contain detectable protein. 
One explanation for this is that the 256-bp sequence encod- 
ing the epitope recognized by c~DVR-6 is spliced out of the 
DVR-6 transcripts in these cell lines and tissues. However, 
RNase protection experiments using this 256-bp sequence as 
a probe in PYS cells show that the sequence is present (Fig. 
4).  Therefore,  a  more plausible explanation for this dis- 
crepancy is that DVR-6 mRNA is not translated in these tis- 
sues and cell lines. However, we cannot rule out the possibil- 
ity that other mechanisms may be involved. DVR-6 protein 
could be degraded as it is translated or it could complex with 
another protein masking the epitope recognized by otDVR-6. 
To explore the possibility of translational control, PYS cells, 
a cell line in which DVR-6 transcript but not protein is de- 
tected,  have  been  stably  transfected  with  hDVR-6.  The 
hDVR-6 construct excludes 5' and 3' untranslated sequences 
since these may be involved in translational control (Her- 
shey, 1991). Preliminary results demonstrate that PYS cells 
are capable of synthesizing DVR-6 protein (data not shown). 
This suggests that translational control via 5' or 3' untrans- 
lated sequences has been relieved. In the embryo, it remains 
to be seen whether translational control plays a role in the 
lack of DVR-6 protein expression in hypertrophic cartilage 
and oocytes. 
Immunohistochemical staining of epithelial and neuronal 
tissues  shows that DVR-6  protein is expressed in vivo at 
different stages of development. In the epidermis, protein is 
first detected at 15.5 d.p.c., when the epidermal thickening 
is beginning to occur, in the suprabasal layers of the nasal 
region. By 16.5 d.p.c., expression is seen in the suprabasal 
layer of the skin and this pattern is maintained in newborns. 
Also in newborns, bronchiolar epithelium is immunoreactive 
for o~DVR-6. Additionally, in the adult, the corneal epithelium, 
but  not the  limbus or  conjunctival epithelium,  expresses 
DVR-6. This is noteworthy because, based on keratin expres- 
sion, the limbal and conjunctival epithelia more closely re- 
semble the basal layer of  the skin while the corneal epithelium 
resembles the suprabasal layer (Schermer et al., 1986). The 
role of DVR-6 in these epithelial tissues is unknown at this 
time. However, since the suprabasal and corneal epithelia are 
differentiated, postmitotic cells, secreted DVR-6 protein may 
act in an autocrine manner to promote withdrawal from the 
cell cycle and/or differentiation. Alternatively, DVR-6 may 
be acting in a paracrine fashion to regulate the proliferation 
and differentiation of basal cells. 
In the nervous system, DVR-6 immunoreactive cells are 
first detected at 9.5 d.p.c, in the trigeminal mesencephalic 
tract, cranial ganglia, and spinal cord.  Also at this stage, 
both the sensory and motor components of the spinal nerves 
begin expressing protein, first anteriorly, and then in more 
posterior sites as development proceeds. Protein is seen in 
both the cytoplasm and axons of neuronal cells at this time. 
This expression is particularly evident in the motor neurons 
of the 10.5-d.p.c.  embryo (Figs. 7 and 8).  Cross sections of 
spinal cord from stages 9.5-15.5  d.p.c, and sagittal sections 
of brain from stages 12.5-adult (data not shown) reveal that 
immunoreactive cells first appear in the outer layers, and 
then subsequently more interior layers of these tissues. This 
temporal and spatial expression pattern suggests that DVR-6 
is expressed in newly born, postmitotic neurons. This hy- 
pothesis will be tested by correlating DVR-6 expression with 
bromodeoxyuridine labeling. 
Flanders et al. (1991) have shown that TGF-fl-2 and TGF- 
fl-3 proteins are expressed in most regions of the embryonic 
nervous system, but not as extensively as DVR-6 protein. For 
example, while DVR-6 is present in all cranial and dorsal 
root ganglia, TGF-Bs  1, 2, and 3 are absent from some of 
these ganglia. Another difference in expression of these pro- 
teins is that TGF-~ is present in some glia in vivo and in vitro 
(Flanders et al.,  1991; Saad et al.,  1991; Constam et al., 
1992;  Lindholm et al.,  1992) but, so far, no expression of 
DVR-6 has been detected in a number of glial cell lines stud- 
ied (data not shown).  Additionally, preliminary studies in 
which sections of the 15.5-d.p.c.  optic nerve have been im- 
munostained and counterstained, do not show staining of 
DVR-6 in cells presumed to be glia associated with the nerve 
tract  (data  not  shown).  If DVR-6  proves  to  be  neuron 
specific, it can be used as an early marker distinguishing be- 
tween neuronal and glial cells. 
The presence  of DVR-6  protein in the cell bodies and 
axons of postmitotic cells of the nervous system suggests a 
variety of potential functions, either paracrine or autocrine 
in nature. Since there is presumably a secreted form of the 
protein, one potential function is the stimulation or inhibi- 
tion of cell division or the promotion of differentiation, of 
associated glial cells, neighboring neurons, innervating neu- 
rons, or target cells, such as muscle. Further studies to deter- 
mine whether DVR-6 is secreted via dendrites or axons (or 
both), and, like other members of the TGF-fl superfamily, it 
is sequestered by the extracellular matrix, will help in deter- 
mining the role of this protein in neural development. It will 
be necessary to produce purified protein and an antibody 
directed against the mature protein (experiments are cur- 
rently under way) before these questions can be fully ad- 
dressed.  Also,  identification and study of a  receptor  for 
DVR-6 will aid in elucidating the function(s) of this protein. 
Immunoprecipitation and Western blot analysis was done 
to rule out the possibility that ctDVR-6 cross-reacts with a 
neurofilament protein. Immunoprecipitation experiments of 
12.5-d.p.c. brain and spinal cord showed that the uncleaved 
form of DVR-6 protein was being synthesized, but at a low 
rate (data not shown), and the results of Western analysis 
show that protein of the expected relative molecular mass for 
the cleaved proregion of DVR-6  is present (Fig. 4).  This 
demonstrates that the appropriate size protein is present in 
tissue extracts and that for steady-state protein levels, the 
predominant form of DVR-6 protein recognized by otDVR-6 
is the cleaved species.  This raises the possibility that the 
staining patterns  seen  in  vivo may be  those of residual, 
cleaved, pro-DVR-6  protein, and not full-length protein. At 
present, the resolution of immunostained sections by light 
microscopy does not allow us to distinguish whether this 
protein  is  entirely  intracellular,  or  whether  the  cleaved 
proregion also accumulates in the extracellular environment. 
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steady-state  protein suggests that it may have a function of 
its own. 
One important conclusion reached using c~DVR-6 is that 
only a subset of tissues previously shown to express DVR-6 
mRNA express the protein.  The PYS cell line (which ex- 
presses DVR-6  transcripts  but not protein)  should provide 
clues as to the mechanism(s) involved in this discrepancy of 
mRNA  and protein expression.  Tissues which do express 
both DVR-6 transcripts  and protein in the mouse are epithe- 
lial and nervous tissues. While the functional role(s) of this 
protein  is  not  known at  this  time,  these  expression  data 
presented here allow us to begin proposing and testing poten- 
tial functions. Additionally, otDVR-6 should be useful as an 
early marker  for neuronal differentiation  in the developing 
nervous system. 
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